drug discovery
Formation builds tech-forward solutions for clinical trials and drug development.
Isomorphic Labs, the London-based, drug discovery–focused spinout of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants, Eli Lilly and Novartis, to…
The biotech startup’s $6.5 million seed round is led by VC firm NFX but it is perhaps equally noteworthy to see that Merck is also participating in the round.
Nearly five years ago, DeepMind, one of Google’s more prolific AI-centered research labs, debuted AlphaFold, an AI system that can accurately predict the structures of many proteins inside the human…
Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery. Today, another hopeful in the space is…
The biotech industry is experiencing a rush of AI-powered tools for many aspects of the complex drug discovery process. But one that has flown under the radar, increasingly thought to…
It’s becoming clear that longevity as a theme has resonated with investors, though it appears it will be some time before more generalist investors take interest.
Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” The firm has raised $35 million on…
TikTok’s parent company ByteDance is making some pretty heavy bets on the healthcare space as it acquired Amcare, which runs high-end children’s and women’s hospitals across China. The buyout cost…
A proposal put forward by European Union lawmakers in May, to establish a legal framework to make it easier to share electronic health records and other medical data — across…
Meta Pharmaceuticals lands $15M to make autoimmune drugs with AI, new immuno-metabolism tech
Biotech startup Meta Pharmaceuticals sets itself an ambitious goal as it secures its initial investment. The Shenzhen-based company, which sets out to develop treatments for autoimmune diseases with the help…
Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. It’s a sign that certain…
Who knows what secrets await in the hearts of plants? Brightseed has found a couple of them, anyway, using an AI-based analysis method and will be bringing its first products…
We believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.
Wicked fast VPNs, data organization tools, auto-generated videos to spice up your company’s Instagram stories … Y Combinator’s Winter 2022 open source founders have some interesting ideas up their sleeves.…
Gandeeva Therapeutics raises $40m zoom in on biomolecules – and create new drugs in the process
The field scientists once jokingly called “blobography” has come a long way. Cryogenic electron microscopy was formerly known for delivering amorphous images of biomolecules. Now it has become one of…
‘How can you understand life if you don’t look at it live?’ — Eikon Therapeutics rakes in $518M
Adam Goulburn, a partner at Lux Capital, was first struck by Eikon Therapeutics’ pitch to use super microscopes to develop drugs when founder Eric Betzig posed a simple question: How…
The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round. Generate Biomedicines is touting…
The field of drug discovery has been supercharged by the capabilities of AI, which several companies have applied in various ways to turn an enormous practical problem into a tractable…
Medable reaches $2.1B valuation as Tiger, Blackstone, GSR pump new capital into clinical trials management company
Medable has grown 300% in the past year and over 800% in the last 18 months, which CEO Michelle Longmire said was proof that a patient-centered approach is taking hold.
There are currently no approved cures for Fragile X syndrome — the most common cause of inherited intellectual disability. At the moment, the treatments are designed to manage symptoms, from…
There’s a clear pain point when it comes to drug discovery: Depending on which study you cite, creating an approved drug costs anywhere from $985 million to $2.6 billion. And…
Genomic data is considered to be the key to unlocking so-called “precision medicine”. Some estimates suggest that by 2025, 500 million human genomes will have been sequenced, but only a…
Human life expectancy increased from 31 years in 1900 to 72 years in 2017. Today, we are on the cusp of another healthcare revolution driven by artificial intelligence.
Psychedelics companies are all the rage right now. Compass Pathways is working with the magic mushroom compound psilocybin to treat depression. It’s has raised $290 million in total. Atai Life…
African genomics startup 54gene raises $25M to expand precision medicine capabilities
Less than 3% of genetic material used in global pharmaceutical research is from Africa. The staggering gap is quite surprising because Africans and people of African descent are reported to…
Extra Crunch Live gives you the chance to hear live from entrepreneurs who have successfully raised significant rounds of venture capital — and from the investors who believed in them.
Absci Corp., a Vancouver company behind a multifaceted drug development platform, went public on Thursday. It’s another sign of snowballing interest in new approaches to drug development — a traditionally…
Insilico Medicine, an AI-based platform for drug development and discovery, announced $255 million in Series C financing on Tuesday. The massive round is reflective of a recent breakthrough for the…
On Monday, a 17-year drought in the world of Alzheimer’s drugs ended with the FDA approval of Biogen’s Aduhlem (aducanumab). The controversy behind the FDA’s decision was considerable, but it…